文献速递白血病

在酪氨酸激酶抑制剂时代,费城染色体的存在并未赋予成人前B急性淋巴细胞白血病不良预后——一项监测、流行病学和最终结果数据库分析

The presence of Philadelphia chromosome does not confer poor prognosis in adult pre-B acute lymphoblastic leukaemia in the tyrosine kinase inhibitor era - a surveillance, epidemiology, and end results database analysis.
PubMed 文献 · Br J Haematol · 2017-10-18

该研究利用美国SEER数据库2010至2014年诊断的2694例成人前B急性淋巴细胞白血病患者(206例Ph+,2488例Ph-),比较酪氨酸激酶抑制剂普及时代Ph+与Ph-患者的生存。Ph+ALL中位总生存32个月(95%CI 18个月-未达到),Ph-ALL为27个月(95%CI 24-30个月),Log-rank检验P=0.34,费城染色体状态未 confer 不良预后。

要点

  • Ph+ALL中位OS 32个月(95%CI 18-未达到)vs Ph-ALL 27个月(95%CI 24-30),Log-rank P=0.34。
  • Ph+ALL和Ph-ALL中,年龄较大均与更差预后相关。
  • 与非西班牙裔白人相比,西班牙裔和非裔美国人的年龄调整OS更差。

核心结论

  • 在TKI时代,费城染色体状态并未赋予前B急性淋巴细胞白血病不良预后,前B ALL的预后因素应据此重新评估。

研究设计与样本

  • 基于美国监测、流行病学和最终结果(SEER)数据库的分析,纳入2010年至2014年诊断的2694例年龄≥18岁的前B ALL患者(206例Ph+ALL,2488例Ph-ALL)。

主要发现

  • Ph+ALL中位总生存为32个月(95%CI 18个月-未达到),Ph-ALL为27个月(95%CI 24-30个月),Log-rank检验P=0.34。
  • 在Ph+ALL和Ph-ALL中,年龄较大均与更差预后相关。
  • 与非西班牙裔白人相比,西班牙裔和非裔美国人的年龄调整总生存更差。
  • 前B ALL的生存随时间持续改善。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The BCR-ABL1 fusion gene is caused by a translocation between chromosomes 9 and 22, resulting in an abnormal chromosome 22 (Philadelphia chromosome; Ph). Prior to the introduction of tyrosine kinase inhibitors (TKI), the presence of BCR-ABL1 conferred a poor prognosis in patients with acute lymphoblastic leukaemia (ALL). We compared the survival of Ph+ and Ph-ALL during the period when TKIs were universally available in the US for Ph+ALL, using a Surveillance, Epidemiology, and End Results (SEER) Database analysis. A total of 2694 patients with pre-B ALL (206 Ph+ALL; 2488 Ph-ALL) aged ≥18 years, who were diagnosed between 2010 and 2014, were identified in SEER registries. The median overall survival (OS) was 32 months in Ph+ALL (95% confidence interval [CI] 18 months-not reached) and 27 months (95% CI 24-30 months) in Ph-ALL (Log-rank test P-value 0·34). Older age was associated with worse prognosis in both Ph+ALL and Ph-ALL. Age-adjusted OS was inferior in Hispanics and African-Americans compared to non-Hispanic whites. Survival of pre-B ALL shows continued improvement with time. Philadelphia chromosome status does not confer poor prognosis in pre-B ALL in the TKI era: prognostic factors in pre-B ALL should be re-evaluated in the light of this finding.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Igwe IJ, Yang D, Merchant A, et al. The presence of Philadelphia chromosome does not confer poor prognosis in adult pre-B acute lymphoblastic leukaemia in the tyrosine kinase inhibitor era - a surveillance, epidemiology, and end results database analysis. Br J Haematol. 2017. PMID: 29047122. doi:10.1111/bjh.14953

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。